S. Koch

发表

Identifying the Molecular Mechanisms Contributing to Progression, Metastasis, and Death in Low-grade Non–muscle-invasive Bladder Cancer: A Case Report

R. Stoehr, R. Wirtz, T. Ecke, 2021, European urology open science.

Prognostic Role of Survivin and Macrophage Infiltration Quantified on Protein and mRNA Level in Molecular Subtypes Determined by RT-qPCR of KRT5, KRT20, and ERBB2 in Muscle-Invasive Bladder Cancer Treated by Adjuvant Chemotherapy

T. Schlomm, K. Jung, T. Brüning, 2020, International journal of molecular sciences.

Comparison of initial and second opinion reads of multiparametric magnetic resonance imaging of the prostate for transperineal template-guided biopsies with MRI-Ultrasound fusion.

S. Koswig, T. Ecke, V. Gnanapragasam, 2021, Urologic oncology.

Different HER2 protein expression profiles aid in the histologic differential diagnosis between urothelial carcinoma in situ (CIS) and non-CIS conditions (dysplasia and reactive atypia) of the urinary bladder mucosa.

A. Erbersdobler, S. Koch, O. Hakenberg, 2011, American journal of clinical pathology.

A switch from epithelial to mesenchymal properties correlates with lymphovascular invasion in squamous cell carcinoma of the penis.

S. Koch, W. Otto, S. Denzinger, 2015, Pathology, research and practice.

Expression of p53, p21 and cyclin D1 in penile cancer: p53 predicts poor prognosis

A. Erbersdobler, S. Koch, O. Hakenberg, 2011, Journal of Clinical Pathology.

Lewisy antigen (blood group 8, BG8) is a useful marker in the histopathological differential diagnosis of flat urothelial lesions of the urinary bladder

A. Erbersdobler, S. Koch, C. Kakies, 2011, Journal of Clinical Pathology.

C-MET is expressed in the majority of penile squamous cell carcinomas and correlates with polysomy-7 but is not associated with MET oncogene amplification, pertinent histopathologic parameters, or with cancer-specific survival.

A. Erbersdobler, S. Koch, O. Hakenberg, 2013, Pathology, research and practice.

Protein gene product 9.5 is diagnostically helpful in delineating high-grade renal cell cancer involving the renal medullary/sinus region from invasive urothelial cell carcinoma of the renal pelvis.

S. Staibano, C. D'Alterio, A. Erbersdobler, 2013, Human pathology.

Scoring the percentage of Ki67 positive nuclei is superior to mitotic count and the mitosis marker phosphohistone H3 (PHH3) in terms of differentiating flat lesions of the bladder mucosa

A. Erbersdobler, S. Koch, C. Kakies, 2012, Journal of Clinical Pathology.

Digital Image Analysis of Mean AgNOR Area Objectively Discriminates between Reactive Plasmacytosis and Multiple Myeloma in Cytologic Smears from Bone Marrow Aspirates

S. Koch, S. Gunia, P.A. Mai, 2008, Pathobiology.

External Validation of an Artificial Neural Network and Two Nomograms for Prostate Cancer Detection

H. Cammann, C. Stephan, K. Miller, 2012, ISRN urology.

Prediction of Response to Cisplatin-Based Neoadjuvant Chemotherapy of Muscle-Invasive Bladder Cancer Patients by Molecular Subtyping including KRT and FGFR Target Gene Assessment

T. Schlomm, R. Wirtz, T. Ecke, 2022, International journal of molecular sciences.

Prospective surveillance of drain associated meningitis/ventriculitis in a neurosurgery and neurological intensive care unit

J. Schiefer, U. Bürgel, S. Koch, 2009, Journal of Neurology, Neurosurgery & Psychiatry.

Chemotherapy with gemcitabine, paclitaxel, and cisplatin in the treatment of patients with advanced transitional cell carcinoma of the urothelium.

T. Ecke, F. Theissig, S. Koch, 2006, Oncology reports.

Do infantile testicular germ cell tumors histogenetically develop from conventional intratubular germ cell neoplasia?

K. Dieckmann, S. Koch, S. Gunia, 2011, Urologic oncology.

Loss of basal cell keratin 14 reflects increased risk of recurrence in surgically resected sinonasal inverted papilloma

S. Koch, D. Liebe, S. Gunia, 2007, Journal of Clinical Pathology.

[How often is bronchopneumonia overlooked as the cause of death in intensive care unit patients?].

S. Koch, S. Gunia, U. Jahn, 2008, Der Anaesthesist.

Do Different Disorders in Cell Cycle Regulation Account for Different Biological Behavior of Urothelial and Sinonasal Inverted Papillomas?

S. Koch, D. Liebe, S. Gunia, 2008, Pathobiology.

Nomograms including the UBC® Rapid test to detect primary bladder cancer based on a multicentre dataset

T. Schlomm, P. Karakiewicz, T. Ecke, 2021, BJU international.

p16(INK4a) is a marker of good prognosis for primary invasive penile squamous cell carcinoma: a multi-institutional study.

A. Erbersdobler, S. Koch, O. Hakenberg, 2012, The Journal of urology.

Recurrent Laryngeal Nerve Palsy after Anterior Cervical Discectomy and Fusion – Prevalence and Risk Factors

S. Koch, M. Stoffel, A. Alfieri, 2020, Journal of Neurological Surgery Part A: Central European Neurosurgery.

Is CDX2 immunostaining useful for delineating anorectal from penile/vulvar squamous cancer in the setting of squamous cell carcinoma with clinically unknown primary site presenting with histologically confirmed inguinal lymph node metastasis?

S. Koch, S. Gunia, M. May, 2012, Journal of Clinical Pathology.

Expression of prostatic acid phosphatase (PSAP) in transurethral resection specimens of the prostate is predictive of histopathologic tumor stage in subsequent radical prostatectomies

Matthias May, Manfred Dietel, Andreas Erbersdobler, 2009, Virchows Archiv.

Molecular identification of telomerase reverse transcriptase (TERT) promotor mutations in primary and recurrent tumors of invasive and noninvasive urothelial bladder cancer.

T. Ecke, S. Koch, J. Roggisch, 2020, Urologic oncology.

Should we abstain from Gleason score 2–4 in the diagnosis of prostate cancer? Results of a German multicentre study

S. Koch, M. Burger, J. Roigas, 2012, World Journal of Urology.

Dural Metastases from Disseminated Prostate Cancer Clinically Mimicking a Benign Reactive Condition of the Dura: Case Report and Review of the Literature

A. Erbersdobler, S. Koch, S. Gunia, 2010, Urologia Internationalis.

Periostin expression correlates with pT-stage, grading and tumour size, and independently predicts cancer-specific survival in surgically treated penile squamous cell carcinomas

S. Koch, S. Denzinger, S. Gunia, 2013, Journal of Clinical Pathology.

Complications and risk factors of transrectal ultrasound guided needle biopsies of the prostate evaluated by questionnaire.

T. Ecke, S. Hallmann, S. Koch, 2008, Urologic oncology.

Does a new ultrasound probe change the complication rates of transrectal ultrasound-guided needle biopsies of the prostate?

T. Ecke, S. Hallmann, S. Koch, 2010, Anticancer research.

GATA3 expression loss is linked to stage progression but is unrelated to prognosis in muscle-invasive urothelial carcinoma of the bladder.

G. Sauter, T. Schlomm, A. Marx, 2022, Human pathology.

Clinical and pathological features of metastatic adenocarcinoma of the prostate to the ileum

T. Ecke, S. Hallmann, S. Koch, 2014, Central European journal of urology.

Expression of CD44s in Incidental Prostate Cancer Is More Strongly Associated with Gleason Scores on Subsequent Radical Prostatectomies than Conventional Prognostic Parameters

M. Dietel, A. Erbersdobler, S. Koch, 2009, Pathobiology.

Is Radical Oncosurgery Justified for the Treatment of Primary Malignant Fibrous Histiocytoma of the Urinary Bladder? Report of Two Cases and Analyses of Disease-Specific Survival Rates Based on a Review of the Literature

A. Erbersdobler, S. Koch, S. Gunia, 2011, Urologia Internationalis.

Diagnostic and prognostic impact of peritumoral stromal remodeling in patients with surgically treated invasive penile squamous cell cancer.

S. Koch, W. Otto, S. Denzinger, 2014, Human pathology.

Inherent Grading Characteristics of Individual Pathologists Contribute to Clinically and Prognostically Relevant Interobserver Discordance Concerning Broders' Grading of Penile Squamous Cell Carcinomas

S. Koch, W. Otto, S. Denzinger, 2012, Urologia Internationalis.

MUC1 Expression in Incidental Prostate Cancer Predicts Staging and Grading on the Subsequent Radical Prostatectomy

M. Dietel, A. Erbersdobler, S. Koch, 2010, Pathology & Oncology Research.

Cytokeratin 20 expression is linked to stage progression and to poor prognosis in advanced (pT4) urothelial carcinoma of the bladder.

G. Sauter, A. Marx, T. Klatte, 2023, Experimental and molecular pathology.

Luminophore Chemistry for Detection of Urinary Bladder Cancer – Comparison to Cytology and Urinary Rapid Tests (BTA stat®, NMP22® BladderChek® and UBC® Rapid Test)

T. Ecke, S. Hallmann, S. Koch, 2022, AntiCancer Research.

Ki67 staining index and neuroendocrine differentiation aggravate adverse prognostic parameters in prostate cancer and are characterized by negligible inter-observer variability

T. Ecke, S. Koch, T. Herrmann, 2008, World Journal of Urology.

Outcome prediction for prostate cancer detection rate with artificial neural network (ANN) in daily routine.

Peter Bartel, Kurt Miller, Henning Cammann, 2012, Urologic oncology.

Gemcitabine, paclitaxel, and cisplatin as combined adjuvant approach in transitional cell carcinoma of the urothelium.

S. Koch, H. Gerullis, P. Bartel, 2009, Minerva urologica e nefrologica = The Italian journal of urology and nephrology.

Ki‐67, mini‐chromosome maintenance 2 protein (MCM2) and geminin have no independent prognostic relevance for cancer‐specific survival in surgically treated squamous cell carcinoma of the penis

S. Koch, W. Otto, S. Denzinger, 2013, BJU international.

Expression of alpha-methylacyl-CoA racemase correlates with histopathologic grading in noninvasive bladder cancer

G. Kristiansen, M. Dietel, S. Koch, 2008, Virchows Archiv.

Does the width of the surgical margin of safety or premalignant dermatoses at the negative surgical margin affect outcome in surgically treated penile cancer?

S. Koch, S. Gunia, M. May, 2013, Journal of Clinical Pathology.